Correlation Between Protara Therapeutics and Zivo Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Protara Therapeutics and Zivo Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protara Therapeutics and Zivo Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protara Therapeutics and Zivo Bioscience, you can compare the effects of market volatilities on Protara Therapeutics and Zivo Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protara Therapeutics with a short position of Zivo Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protara Therapeutics and Zivo Bioscience.

Diversification Opportunities for Protara Therapeutics and Zivo Bioscience

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Protara and Zivo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Protara Therapeutics and Zivo Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zivo Bioscience and Protara Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protara Therapeutics are associated (or correlated) with Zivo Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zivo Bioscience has no effect on the direction of Protara Therapeutics i.e., Protara Therapeutics and Zivo Bioscience go up and down completely randomly.

Pair Corralation between Protara Therapeutics and Zivo Bioscience

If you would invest  211.00  in Protara Therapeutics on November 9, 2024 and sell it today you would earn a total of  274.00  from holding Protara Therapeutics or generate 129.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Protara Therapeutics  vs.  Zivo Bioscience

 Performance 
       Timeline  
Protara Therapeutics 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Protara Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Protara Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.
Zivo Bioscience 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Zivo Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Zivo Bioscience is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Protara Therapeutics and Zivo Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Protara Therapeutics and Zivo Bioscience

The main advantage of trading using opposite Protara Therapeutics and Zivo Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protara Therapeutics position performs unexpectedly, Zivo Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zivo Bioscience will offset losses from the drop in Zivo Bioscience's long position.
The idea behind Protara Therapeutics and Zivo Bioscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account